Rigel Pharmaceuticals reported $24.68M in Cash and Equivalent for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Agenus AGEN:US $ 247.71M 44.22M
Amgen AMGN:US $ 6528M 1461M
Anika Therapeutics ANIK:US $ 90.32M 4.06M
Applied Genetic Technologies AGTC:US $ 67.85M 4.92M
Arrowhead Research ARWR:US $ 86.41M 5.18M
Astrazeneca AZN:US $ 5762M 567M
AstraZeneca AZN:LN 5762M 567M
Biomarin Pharmaceutical BMRN:US $ 605.44M 18.16M
Bristol Myers Squibb BMY:US $ 12369M 1610M
Celldex Therapeutics CLDX:US $ 25.29M 13.85M
Chemocentryx CCXI:US $ 40.58M 9.4M
Daiichi Sankyo 4568:JP Y 662477M 85182M
Eli Lilly And LLY:US $ 2459.2M 1359.3M
Halozyme Therapeutics HALO:US $ 117.84M 0.88M
Heron Therapeutics HRTX:US $ 56.91M 33.63M
Immunogen IMGN:US $ 437.66M 41.09M
Intrexon XON:US $ 40.32M 2.6M
Karyopharm Therapeutics KPTI:US $ 153.26M 37.2M
Ligand Pharmaceuticals LGND:US $ 14.99M 4.53M
Macrogenics MGNX:US $ 47.33M 76.14M
Neurocrine Biosciences NBIX:US $ 270.2M 70.6M
Pfizer PFE:US $ 2470M 526M
Regeneron Pharmaceuticals REGN:US $ 3345.7M 460.1M
Rigel Pharmaceuticals RIGL:US $ 24.68M 5.79M
Sangamo Biosciences SGMO:US $ 120.26M 58.62M
Ultragenyx Pharmaceutical RARE:US $ 153.99M 153.6M
Veracyte VCYT:US $ 163.62M 9.58M